Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Abstract The molecular heterogeneity of feline mammary carcinomas (FMCs) represents a prognostic and therapeutic challenge. RNA-Seq-based comparative transcriptomic profiling serves to identify recurrent and exclusive differentially expressed genes (DEGs) across sample types and molecular subtypes....

Full description

Bibliographic Details
Main Authors: José Luis Granados-Soler, Leila Taher, Julia Beck, Kirsten Bornemann-Kolatzki, Bertram Brenig, Verena Nerschbach, Fernando Ferreira, Johannes Junginger, Marion Hewicker-Trautwein, Hugo Murua Escobar, Ingo Nolte
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-20874-5

Internet

https://doi.org/10.1038/s41598-022-20874-5

Similar Items